A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome

Phase 3 Not yet recruiting 38 enrolled Kedrion S.p.A.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of QIVIGY (Intravenous Human Normal Immune Globulin 10%) compared with placebo in adult participants with stiff person syndrome (SPS).

Timeline

Start: 2026-09
Primary completion: 2028-01
Completion: 2028-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Immune Globulin Intravenous (Human)	Protein / enzyme biologic	2 g/kg	Intravenous

A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome

Summary

Timeline

Drugs

Indications